Evidence map›Paper›PMID 28132691›Full record

ArticleAmerican journal of human genetics2017

De Novo Disruption of the Proteasome Regulatory Subunit PSMD12 Causes a Syndromic Neurodevelopmental Disorder.

Sébastien Küry, Thomas Besnard, Frédéric Ebstein, Tahir N Khan, Tomasz Gambin, Jessica Douglas, Carlos A Bacino, William J Craigen, Stephan J Sanders, Andrea Lehmann and 51 more

Erratum issuedOpen access · bronzeAbstract readCase Reports
In one paragraph

Article in American journal of human genetics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 65 papers.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

65 citing papers in PubMed, 108 citations in OpenAlex.

  1. Article
  2. Article
  3. The E3 Ubiquitin Ligase UBE3B Regulates Synaptic Development and Cortical Network Activity.Autism research : official journal of the International Society for Autism Research · 2026
    Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Biallelic USP14 variants cause a syndromic neurodevelopmental disorder.Genetics in medicine : official journal of the American College of Medical Genetics · 2024
    Article
  17. Article
  18. Article
  19. Article
  20. Article

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

61 authors at 20 institutions in 5 countries.

Sébastien KüryService de Génétique Médicale, CHU de Nantes, 9 quai Moncousu, 44093 Nantes Cedex 1, France.
Thomas BesnardService de Génétique Médicale, CHU de Nantes, 9 quai Moncousu, 44093 Nantes Cedex 1, France.
Frédéric EbsteinInstitute of Biochemistry, Charité Universitätsmedizin Berlin, Charité Platz 1/Virchowweg 6, 10117 Berlin, Germany.
Tahir N KhanCenter for Human Disease Modeling, Duke University Medical Center, Durham, NC 27710, USA.
Tomasz GambinDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA; Institute of Computer Science, Warsaw University of Technology, Warsaw 00-661, Poland; Department of Medical Genetics, Institute of Mother and Child, Warsaw 01-211, Poland.
Jessica DouglasDivision of Genetics and Genomics, Boston Children's Hospital and Harvard Medical School, Boston, MA 02115, USA.
Carlos A BacinoDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA; Baylor Genetics, Houston TX, 77030, USA.
William J CraigenDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA; Baylor Genetics, Houston TX, 77030, USA.
Stephan J SandersDepartment of Psychiatry, Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA 94158, USA.
Andrea LehmannInstitute of Biochemistry, Charité Universitätsmedizin Berlin, Charité Platz 1/Virchowweg 6, 10117 Berlin, Germany.
Xénia LatypovaService de Génétique Médicale, CHU de Nantes, 9 quai Moncousu, 44093 Nantes Cedex 1, France.
Kamal KhanCenter for Human Disease Modeling, Duke University Medical Center, Durham, NC 27710, USA.
Mathilde PacaultService de Génétique Médicale, CHU de Nantes, 9 quai Moncousu, 44093 Nantes Cedex 1, France.
Stephanie SacharowDivision of Genetics and Genomics, Boston Children's Hospital and Harvard Medical School, Boston, MA 02115, USA.
Kimberly GlaserDr. John T. Macdonald Foundation Department of Human Genetics, Miller School of Medicine, University of Miami, Miami, FL 33136, USA.
Eric BiethService de Génétique Médicale, Hôpital Purpan, CHU de Toulouse, 31059 Toulouse, France.
Laurence Perrin-SabourinFédération de Génétique, Hôpital Robert Debré, Assistance Publique - Hôpitaux de Paris, 75935 Paris Cedex 19, France.
Marie-Line JacquemontGénétique Médicale, CHU de La Réunion, 97448 Saint Pierre, La Réunion, France.
Megan T ChoGeneDx, Gaithersburg, MD 20877, USA.
Elizabeth RoederDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA; Department of Pediatrics, Baylor College of Medicine, San Antonio, TX 78207, USA.
Anne-Sophie Denommé-PichonDépartement de Biochimie et Génétique, CHU d'Angers, 49933 Angers Cedex 9, France.
Kristin G MonaghanGeneDx, Gaithersburg, MD 20877, USA.
Bo YuanDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA; Baylor Genetics, Houston TX, 77030, USA.
Fan XiaDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA; Baylor Genetics, Houston TX, 77030, USA.
Sylvain SimonCentre de Recherche en Cancérologie et Immunologie Nantes-Angers, INSERM, Université d'Angers et Université de Nantes, 44007 Nantes, France; LabEx "Immunotherapy, Graft, Oncology," 44093 Nantes, France; Department of Dermato-cancerology, CHU de Nantes, 44093 Nantes, France.
Dominique BonneauDépartement de Biochimie et Génétique, CHU d'Angers, 49933 Angers Cedex 9, France; INSERM UMR 1083, CNRS UMR 6214, 49933 Angers Cedex 9, France.
Philippe ParentGénétique Médicale, CHRU de Brest, 29609 Brest, France.
Brigitte Gilbert-DussardierService de Génétique, CHU de Poitiers, BP 577, 86021 Poitiers, France; Equipe d'Accueil 3808, Université de Poitiers, 86022 Poitiers Cedex, France.
Sylvie OdentService de Génétique Clinique, Centre Hospitalier Universitaire de Rennes, 35203 Rennes, France; CNRS UMR 6290, Université de Rennes 1, 2 Avenue du Professeur Léon Bernard, 35043 Rennes, France.
Annick ToutainService de Génétique, CHU de Tours, 2 Boulevard Tonnellé, 37044 Tours, France; INSERM UMR U930, Faculté de Médecine, Université François Rabelais, 37044 Tours, France.
Laurent PasquierService de Génétique Clinique, Centre Hospitalier Universitaire de Rennes, 35203 Rennes, France; CNRS UMR 6290, Université de Rennes 1, 2 Avenue du Professeur Léon Bernard, 35043 Rennes, France.
Deborah BarbouthDr. John T. Macdonald Foundation Department of Human Genetics, Miller School of Medicine, University of Miami, Miami, FL 33136, USA.
Chad A ShawDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA; Baylor Genetics, Houston TX, 77030, USA.
Ankita PatelDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA; Baylor Genetics, Houston TX, 77030, USA.
Janice L SmithDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA; Baylor Genetics, Houston TX, 77030, USA.
Weimin BiDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA; Baylor Genetics, Houston TX, 77030, USA.
Sébastien SchmittService de Génétique Médicale, CHU de Nantes, 9 quai Moncousu, 44093 Nantes Cedex 1, France.
Wallid DebService de Génétique Médicale, CHU de Nantes, 9 quai Moncousu, 44093 Nantes Cedex 1, France.
Mathilde NizonService de Génétique Médicale, CHU de Nantes, 9 quai Moncousu, 44093 Nantes Cedex 1, France.
Sandra MercierService de Génétique Médicale, CHU de Nantes, 9 quai Moncousu, 44093 Nantes Cedex 1, France.
Marie VincentService de Génétique Médicale, CHU de Nantes, 9 quai Moncousu, 44093 Nantes Cedex 1, France.
Caroline RooryckService de Génétique Médicale, CHU de Bordeaux, 33076 Bordeaux, France.
Valérie MalanService d'Histologie-Embryologie-Cytogénétique, Hôpital Necker-Enfants Malades, Assistance Publique - Hôpitaux de Paris, 75015 Paris, France.
Ignacio BriceñoInstituto de Genética Humana, Facultad de Medicina, Pontificia Universidad Javeriana, 110231 Bogotá, Colombia.
Alberto GómezInstituto de Genética Humana, Facultad de Medicina, Pontificia Universidad Javeriana, 110231 Bogotá, Colombia.
Kimberly M NugentDepartment of Pediatrics, Baylor College of Medicine, San Antonio, TX 78207, USA.
James B GibsonClinical and Metabolic Genetics, 'Specially for Children, Austin, TX 78723, USA.
Benjamin CognéService de Génétique Médicale, CHU de Nantes, 9 quai Moncousu, 44093 Nantes Cedex 1, France.
James R LupskiDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA; Department of Pediatrics, Texas Children's Hospital, Houston, TX 77030, USA; Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX 77030, USA.
Holly A F StessmanDepartment of Genome Sciences, University of Washington School of Medicine, Seattle, WA 98195, USA.
Evan E EichlerDepartment of Genome Sciences, University of Washington School of Medicine, Seattle, WA 98195, USA; Howard Hughes Medical Institute, Seattle, WA 98195, USA.
Kyle RettererGeneDx, Gaithersburg, MD 20877, USA.
Yaping YangDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA; Baylor Genetics, Houston TX, 77030, USA.
Richard RedonINSERM, CNRS, l'Institut du Thorax, Université de Nantes, 44007 Nantes, France; L'Institut du Thorax, CHU de Nantes, 44093 Nantes, France.
Nicholas KatsanisCenter for Human Disease Modeling, Duke University Medical Center, Durham, NC 27710, USA; Department of Cell Biology, Duke University Medical Center, Durham, NC 27710, USA.
Jill A RosenfeldDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA.
Peter-Michael KloetzelInstitute of Biochemistry, Charité Universitätsmedizin Berlin, Charité Platz 1/Virchowweg 6, 10117 Berlin, Germany.
Christelle GolzioCenter for Human Disease Modeling, Duke University Medical Center, Durham, NC 27710, USA.
Stéphane BézieauService de Génétique Médicale, CHU de Nantes, 9 quai Moncousu, 44093 Nantes Cedex 1, France; Centre de Recherche en Cancérologie et Immunologie Nantes-Angers, INSERM, Université d'Angers et Université de Nantes, 44007 Nantes, France.
Paweł StankiewiczDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA; Baylor Genetics, Houston TX, 77030, USA; Institute of Mother and Child, Warsaw 01-211, Poland. Electronic address: pawels@bcm.edu.
Bertrand IsidorService de Génétique Médicale, CHU de Nantes, 9 quai Moncousu, 44093 Nantes Cedex 1, France. Electronic address: bertrand.isidor@chu-nantes.fr.
Baylor College of Medicine · USCentre Hospitalier Universitaire de Nantes · FRBaylor Genetics · USGénétique Médicale & Génomique Fonctionelle · FRCharité - Universitätsmedizin Berlin · DEAssistance Publique – Hôpitaux de Paris · FRBoston Children's Hospital · USDr. John T. Macdonald Foundation · USDuke University Hospital · USInserm · FRPontificia Universidad Javeriana · COCentre Hospitalier Universitaire d'Angers · FRCentre Hospitalier Universitaire de Bordeaux · FRCentre Hospitalier Universitaire de Toulouse · FRCentre Hospitalier Universitaire de Tours · FRCentre National de la Recherche Scientifique · FRDuke Medical Center · USDuke University · USGénétique, Génomique Fonctionnelle et Biotechnologies · FRHoward Hughes Medical Institute · US

Funding

Baylor-Johns Hopkins Center for Mendelian GeneticsU54HG006542 · NHGRI · JOHNS HOPKINS UNIVERSITY · PI VALLE, DAVID · 2012 to 2015
$15.6M
Renal Genomics CoreP30DK096493 · NIDDK · DUKE UNIVERSITY · PI PATEL, UPTAL D · 2012 to 2016
$5.9M
NHGRI NIH HHS U54 HG006542NIDDK NIH HHS P30 DK096493Wellcome Trust
6 · The paper itself

Abstract

Degradation of proteins by the ubiquitin-proteasome system (UPS) is an essential biological process in the development of eukaryotic organisms. Dysregulation of this mechanism leads to numerous human neurodegenerative or neurodevelopmental disorders. Through a multi-center collaboration, we identified six de novo genomic deletions and four de novo point mutations involving PSMD12, encoding the non-ATPase subunit PSMD12 (aka RPN5) of the 19S regulator of 26S proteasome complex, in unrelated individuals with intellectual disability, congenital malformations, ophthalmologic anomalies, feeding difficulties, deafness, and subtle dysmorphic facial features. We observed reduced PSMD12 levels and an accumulation of ubiquitinated proteins without any impairment of proteasome catalytic activity. Our PSMD12 loss-of-function zebrafish CRISPR/Cas9 model exhibited microcephaly, decreased convolution of the renal tubules, and abnormal craniofacial morphology. Our data support the biological importance of PSMD12 as a scaffolding subunit in proteasome function during development and neurogenesis in particular; they enable the definition of a neurodevelopmental disorder due to PSMD12 variants, expanding the phenotypic spectrum of UPS-dependent disorders.

Indexed as

AdolescentAnimalsChildChild, PreschoolDisease Models, AnimalDNA Copy Number VariationsDown-RegulationFemaleGene DeletionHumansInfantIntellectual DisabilityMaleMicrocephalyNeurodevelopmental DisordersPolymorphism, Single Nucleotide26S proteasome non-ATPase regulatory subunit 13Proteasome Endopeptidase Complexintellectual disabilityproteasome 26SPSMD12RPN5syndromic neurodevelopmental disorderubiquitin

Identifiers

PMID28132691
PMCPMC5294671
OpenAlexW2580973364

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.